Engineered probiotic alleviates ulcerative colitis by inhibiting M1 macrophage polarization via glycolytic reprogramming.
Saved in:
| Title: | Engineered probiotic alleviates ulcerative colitis by inhibiting M1 macrophage polarization via glycolytic reprogramming. |
|---|---|
| Authors: | Lv, Chaoqun1 (AUTHOR), Hu, Xinyue1 (AUTHOR), Li, Xiang1 (AUTHOR), Shi, Wen1 (AUTHOR), Li, Wenbo1 (AUTHOR), He, Yan1 (AUTHOR), Li, Hongqing2 (AUTHOR), Bai, Jianxi1 (AUTHOR), Li, Zhenxing1 (AUTHOR), Wen, Zhipeng1 (AUTHOR), Liu, Xinxin1 (AUTHOR), Ai, Yuanyuan1 (AUTHOR), Li, Jingchao2 (AUTHOR), Chen, Xiao2 (AUTHOR) xiaochen229@tmmu.edu.cn, Liu, Kaijun1 (AUTHOR) kliu@tmmu.edu.cn |
| Source: | Bioengineering & Translational Medicine. Nov2025, Vol. 10 Issue 6, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23806761 |
|---|---|
| DOI: | 10.1002/btm2.70067 |